Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-18-000896

Director sold 7,118 shares at $63.00 ($448,434)

  • Director acquired 7,118 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KROLL MARK W · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-01-02 Exercise or conversion : show line 1 in the form +7,118 $34.41 $244,895 33,881 D
2018-01-02 Sale : show line 2 in the form −7,118 $63.00 $448,434 26,763 D
Open-market sales · 7,118 sh · avg $63.00 · $448,434

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) −7,118 0 D
Loading xslF345X03/form4.xml…